About UNLOXCYT™ (cosibelimab-ipdl) UNLOXCYT is a human immunoglobulin G1 (“IgG1”) monoclonal ... Monitor closely for signs and symptoms of immune-mediated adverse reactions. Evaluate liver enzymes, ...
Immune checkpoint blockades, or ICBs, have revolutionized treatment for various advanced cancers. However, their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback